Log In
BCIQ
Print this Print this
 

WT1-CTL

  Manage Alerts
Collapse Summary General Information
Company Memorial Sloan Kettering Cancer Center
DescriptionWilms tumor 1 (WT1)-specific cytotoxic T lymphocytes
Molecular Target Wilms tumor 1 (WT1)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$33.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/23/2014

Undisclosed

0

$33.0M

Get a free BioCentury trial today